Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07157059 · ClinicalTrials.gov registry record · NA
Labor and Delivery Doula Program to Reduce Perinatal Morbidity and Mortality in Kansas
A NA study, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT07157059: Completed NA study, sponsored by University of Kansas Medical Center.
NCT07157059 is a NA study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07157059, a NA study, has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The study was done to learn how doula-enhanced care provided to Black birthing people improved perceived communication and quality care.
Primary Outcome
Assess patient's perception of their quality of communication with their provider using a Likert scale survey (ie. did the patient feel comfortable asking their prenatal provider questions regarding their health, did the patient feel listened to by their provider. Survey scale was 1 to 5 and correlated with agreement or disagreement. Reporting Likert's mean score as surveys were collected at three study timepoints (1. Baseline at study enrollment, 2. Immediate postdelivery, 3. 6-weeks postpartum
Interventions
- BEHAVIORAL Doula Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-05-12 |
| Est. Completion | 2024-11-01 |
| Phase | NA |
What the finished NCT07157059 record still lists
NCT07157059 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Doula Care is the first listed.
NCT07157059 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07157059 about?
NCT07157059 is a clinical study titled "Labor and Delivery Doula Program to Reduce Perinatal Morbidity and Mortality in Kansas". The study was done to learn how doula-enhanced care provided to Black birthing people improved perceived communication and quality care.
What is the current status of trial NCT07157059?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2023-05-12. Estimated completion is 2024-11-01.
What interventions are being tested in trial NCT07157059?
The interventions under investigation include: Doula Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT07157059?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07157059's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI